Where Does Epocrates DocAlert Content Come From?
Our Content Sources | Our Editorial Process | Sponsored DocAlerts
Epocrates DocAlert Content
Our Content Sources
Epocrates is dedicated to providing physicians and other healthcare professionals
with the most accurate, current, concise, and relevant information for your practice.
In order to provide our users with general interest and specialty information, we select DocAlert content from a wide variety of authoritative sources, and continually look for new sources of valuable information for our members.
New Sources
This year, we’re excited to have new DocAlert partnerships with:
- JournalWatch – commentary and evidence-based medicine
- InfoPOEMs – evidence-based medicine (“Patient-Oriented Evidence that Matters”)
- Neurology – journal abstracts
Other Sources
Our information sources and partners also include:
- HealthDay
- Reuters Health
- MEDLINE
- MedPage Today
- Primary Psychiatry
- Journal of American College of Cardiology (JACC)
DocAlert messages may also include relevant Epocrates news such as summaries of the latest clinical database updates, links to new free MedTools applications and MobileCME activities, new product announcements, and feature enhancements.
In addition, we also send a limited number of commercially sponsored messages from third parties such as pharmaceutical, biotechnology, and CME companies. See Sponsored DocAlerts below.
Our Editorial Process
The Epocrates DocAlert editors carefully select the most clinically useful content to send to our members. To determine what is most valuable, they solicit user feedback and monitor the readership of each message.
Prior to dissemination, all information must pass through our editorial review process, which includes review by our Medical Information team of practicing physicians and pharmacists. We believe this process helps to ensure that only accurate, scientifically supported, and clinically useful information is sent to our customers.
To save you time, we also summarize the content to fit our user-friendly, scannable format. If you want to read more on the topic, you can request in-depth information by email.
Sponsored DocAlerts
A limited number of DocAlert messages are sponsored by third parties such
as pharmaceutical, biotechnology, and CME companies who wish to share new clinical
study results, drug information, or educational opportunities with our members.
As with all of our clinical DocAlert messages, these sponsored messages are subject
to our review process.
So that you can quickly identify the source, these messages begin with “Sponsored by” and the name of the sponsor (see example on the right).